Francisco Gimenez
Principal at 8VC
San Francisco, California
Overview
Work Experience
Partner
2020 - Current
Principal
2016
Healthcare and Biotech investing in Seed and Series A stage companies
Resident Data Scientist
2016 - 2016
* Building community of data scientists within bay area * Academic outreach for data science recruitment * Help portfolio companies develop data science strategy * Prototype/debug/deploy data products for startups
8VC transform the technology infrastructure behind many industries.
Board Observer
2021
Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.
Raised $213,714,701.00 from PremjiInvest.
Board Observer
2021
Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies.
Raised $122,500,002.00 from Advanced Research Projects Agency for Health.
Director Board of Directors
2021
Appia Bio is a biotechnology company that focuses on the research and development of off-the-shelf allogeneic cell therapies.
Raised $52,000,000.00 from 8VC, Sherpa Healthcare Partners, Two Sigma Ventures, Freeflow Ventures, WPSS.bio and Bossa Invest.
Director Board Of Directors
2021
Flywheel.io is a data management and analysis platform built specifically for scientists and the researcher's workflow.
Raised $105,289,919.00 from iSelect Fund, Novalis LifeSciences, Key Fund, Beringea, 8VC, Gundersen Health System, Seraph Group, Great North Ventures, Intuitive Ventures and Invenshure.
Director Board Of Directors
2020
Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.
Raised $134,850,000.00 from Wittington Ventures, Radical Ventures, DCVC Bio, DCVC, 8VC, Insight Partners, EPIC Ventures, Mubadala Capital, Necessary Ventures and Altimeter Capital.
Director Board Of Directors
2019
BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.
Raised $99,302,511.00 from Gaingels, 8VC, Andreessen Horowitz, Amgen Ventures, Bristol-Myers Squibb, Quadrille Capital, GRIDS Capital, AME Cloud Ventures and Section 32.
Director Board Of Directors
2019
Mantra is developing engineered exosomes for delivery of gene therapy machinery and small molecules. The company is working to produce exosomes with combinations of surface-associated targeting moieties that lead to highly selective uptake in particular tissue and cell types of interest. Their efforts have yielded dramatic reductions in liver concentrations with corresponding increases in delivery levels to specific tissues. They are leveraging these results to generate new formulations of drugs otherwise demonstrating unacceptable toxicity levels when administered systemically.
Mantra Bio is the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation.
Raised $34,000,000.00 from Samsung Securities, Illumina, BoxGroup, Allen & Company, 8VC, Viking Global Investors, Viking Global Investors, Allen & Company, 8VC and BoxGroup.
Director Board of Directors
2019
Sirona Medical develops software solutions for healthcare providers that support patient care and clinical workflows.
Raised $104,500,000.00 from Avidity Partners, GreatPoint Ventures and 8VC.
Director Board of Directors
2019
Cambium develops biomaterials for applications across defense, space, aerospace, and renewable energy.
Raised $27,012,877.00 from 8VC, Kern Venture Group, MVP Ventures, Gaingels, Veteran Ventures Capital, Marlinspike Capital, Vertical Capital Advisors and GSBackers.
Education
PhD
2010 - 2015
B.S.
2005 - 2009
High School
2001 - 2005